CT1 constellation technologies limited

Sinopharm Substantially Increases Purchase of Agenix Anti-HBV...

  1. 597 Posts.
    lightbulb Created with Sketch. 50
    Sinopharm Substantially Increases Purchase of Agenix Anti-
    HBV Drug – First Delivery by Early December 2007
    Probable that combined sales achieved by Sinopharm and own sales
    force will reach RMB100 million (A$15.2 million) in 2008 calendar
    year
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.001(33.3%)
Mkt cap ! $2.949M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $53 26.33K

Buyers (Bids)

No. Vol. Price($)
48 51452991 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 7743393 9
View Market Depth
Last trade - 10.21am 08/08/2025 (20 minute delay) ?
CT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.